Category: Oncology/Hematology
North America Oncology/Hematology
-
2022 Global Immunodiagnostic Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic market during the next five years. The report explores ... Read More
-
2022-2026 US Clinical Chemistry Market Database - Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... available from any other published source . The report is available by section, and can be customized to specific information needs and budget. This database from LeadingMarketResearch.com provides the 2021 supplier shares, the 2021-2026 volume ... Read More
-
2022-2026 Global Clinical Chemistry Market Database for the US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . The report is available by section, and can be customized to specific information needs and budget. This database from LeadingMarketResearch.com provides the 2021 ... Read More
-
2022-2026 Canada Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing ... Read More
-
2022-2026 US Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 Mexico Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies ... Read More
-
U.S. Solid Tumor Testing Market - A Country Analysis: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032
... Overview The U.S. solid tumor testing market was estimated to be at $9,498.8 million in 2021, which is expected to grow with a CAGR of 6.19% during the forecast period 2022-2032 and reach $18,287.6 million ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 – 2028
... 2028 The North America Antibody Drug Conjugates Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028). ADCs are anticancer medications that are one of the quickest treatments for cancer patients, with ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
DNA/Gene Microarray Market, By Type (oDNA, cDNA), By Application (Genomics, Proteomics, Agricultural biology, Environment, Drug R&D, Gene expression and SNP analysis, Cancer/oncology, Others), and By Region (North America, Latin America, Europe, Asia Paci
... & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is ... Read More
-
Medical Tourism Market, by Treatment Type (Cardiovascular, Orthopedic, Neurological, Cancer, Fertility and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysi
... - 2028 Medical tourism refers to people traveling abroad to obtain medical treatment. Factors such as high cost of healthcare and long waiting time for certain procedures have increased the popularity of medical tourism. Domestic ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and A
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More
-
2022-2026 Mexico Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
Car T Cell Therapy Market, by Type (Abecma, Breyanzi, Kymriah, Tecartus, and Yescarta), by Application (Cancer, Lymphoma, and Others), by End Users (Hospitals, Specialty Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacif
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that modifies a patient’s immune system so it ... Read More
-
North America Outbound Medical Tourism Services Market, By Therapeutic Application (Cosmetic Surgery Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedic Treatment, Cancer Treatment, Fertility Treatment, Weight Loss Treatment, Spinal Surgery
... By Countries (U.S., Canada) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Outbound medical tourism is defined as traveling of patients outside their country to avail various medical treatments. The preferred countries by ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
North America Oncology Market Databank
... treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is ... Read More
-
Nucleic Acid Testing (NAT) Market: US, Europe, Japan-Supplier Sales and Shares by Test, Volume and Sales Forecasts for 100 Infectious, Cancer and Genetic Diseases, Forensic and Paternity Testing/HLA Typing-Technological Breakthroughs, Emerging Tests, Competitive Analysis
... new seven-country study from LeadingMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Highlights Business and ... Read More
-
Hematology and Flow Cytometry: US, Europe, Japan-A Market Facing Regulatory and Competitive Challenges-Supplier Shares and Segment Forecasts by Test-Technological Breakthroughs, Emerging Tests, Competitive Analysis
... potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the US, Europe (France, Germany, ... Read More
-
2022-2026 Succeeding in the Global Hematology and Flow Cytometry Market: US, Europe, Japan - Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers
... This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More